Abstract

Most aspects of normal cellular behaviour are subverted in the development of tumours. These changes include a switch to aberrant signalling in both pro- and anti-proliferative pathways, the acquisition of the capacity to avoid cell death and to replicate indefinitely, and perturbation of the normal metabolic profile. In addition, dynamic interactions between tumours and normal cells in their environment can progressively co-opt inflammatory and immune responses so that they support rather than inhibit tumour growth and can recruit host endothelium to provide a blood supply. The defining feature of malignant tumours is the ability of cells to migrate through adjacent tissue and eventually to colonise distant sites. This process of metastasis is poorly understood at the molecular level. It remains essentially untreatable and is the major cause of cancer death. Introduction Cancer is a group of diseases characterised by abnormal cell growth through which cells may acquire the potential to disperse (metastasise) from the site of origin (primary tumour) to other sites in the body (secondary tumours). The word tumour comes from the Latin ‘ tumor ’ referring to the swelling that occurs as a consequence of these abnormal growths and is now used interchangeably with ‘neoplasm’, meaning new or abnormal cell growth. This definition of neoplasm leads to a major division of cancers into malignant and benign . The terms ‘tumour’ and ‘cancer’ have also come to be used synonymously but a distinction might be made in that metastatic cancer occurs because a tumour has acquired the capacity to invade its surroundings, the first step in spreading to secondary sites. This involves the destruction of other cells, critically some that make up the vessels of the circulatory (blood and lymphatic) systems. Once the tumour cell can get into the circulation it can be carried to other locations: it has become malignant. The implication, of course, is that there are tumours that are not malignant.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.